United States · FDA National Drug Code directory

Atovaquone and Proguanil Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-3160_fc935266-98cd-4a37-9b59-bdc6f0910b80
Product NDC
71335-3160
Form
TABLET, FILM COATED
Composition / generic term
Atovaquone and Proguanil Hydrochloride
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20110915
Source listing expiry
20271231

Source-listed ingredients

  • ATOVAQUONE — 250 mg/1
  • PROGUANIL HYDROCHLORIDE — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 TABLET, FILM COATED in 1 BOTTLE (71335-3160-1) · 71335-3160-1
  • 24 TABLET, FILM COATED in 1 BOTTLE (71335-3160-2) · 71335-3160-2
  • 5 TABLET, FILM COATED in 1 BOTTLE (71335-3160-3) · 71335-3160-3
  • 12 TABLET, FILM COATED in 1 BOTTLE (71335-3160-4) · 71335-3160-4
  • 100 TABLET, FILM COATED in 1 BOTTLE (71335-3160-5) · 71335-3160-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →